These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22202200)

  • 1. Synthesis, in vitro anticancer screening and radiosensitizing evaluation of some new 4-[3-(substituted)thioureido]-N-(quinoxalin-2-yl)-benzenesulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MG
    Acta Pharm; 2011 Dec; 61(4):415-25. PubMed ID: 22202200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MG
    Arzneimittelforschung; 2012 Jan; 62(1):46-52. PubMed ID: 22331763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
    Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 4-(4-substituted-thiazol-2-ylamino)-N-(pyridin-2-yl)-benzenesulfonamides as cytotoxic and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Agha HM; Nissan YM
    Arch Pharm Res; 2012 Jan; 35(1):59-68. PubMed ID: 22297743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
    Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of some novel 4-Chloro-N-(4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Soliman AM
    Eur J Med Chem; 2016 Jul; 117():8-18. PubMed ID: 27085944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives.
    El-Said MS; El-Gazzar MG; Al-Dosari MS; Ghorab MM
    Arzneimittelforschung; 2012 Mar; 62(3):149-56. PubMed ID: 22270843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
    Al-Said MS; Ghorab MM; Al-Qasoumi SI; El-Hossary EM; Noaman E
    Eur J Med Chem; 2010 Jul; 45(7):3011-8. PubMed ID: 20413187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MGM
    Bioorg Med Chem Lett; 2018 May; 28(9):1464-1470. PubMed ID: 29628325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of methyl 2-isothiocyanatobenzoate in the synthesis of some new quinazoline derivatives as potential anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Bayomi AA
    Arzneimittelforschung; 2011; 61(12):719-26. PubMed ID: 22282960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety.
    Ghorab MM; Shaaban MA; Refaat HM; Heiba HI; Ibrahim SS
    Eur J Med Chem; 2012 Jul; 53():403-7. PubMed ID: 22583778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; El-Hazek RM
    Eur J Med Chem; 2011 Oct; 46(10):5120-6. PubMed ID: 21890248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of some new pyrazole and pyrimidine derivatives carrying a sulfonamide moiety of expected antitumor activity and study of the synergistic effect of gamma-irradiation.
    Ghorab MM; Ragab FA; Heiba HI; Youssef HA; Galal M
    Arzneimittelforschung; 2010; 60(1):48-55. PubMed ID: 20184227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of γ-radiation.
    Ghorab MM; Ragab FA; Heiba HI; Nissan YM; Ghorab WM
    Arch Pharm Res; 2012 Aug; 35(8):1335-46. PubMed ID: 22941476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pyrazole derivatives as anticancer and radiosensitizing agents.
    Aly HM; El-Gazzar MG
    Arzneimittelforschung; 2012 Mar; 62(3):105-12. PubMed ID: 22407898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of some new 1-benzyl and 1-benzoyl-3-heterocyclic indole derivatives.
    El-Sawy ER; Bassyouni FA; Abu-Bakr SH; Rady HM; Abdlla MM
    Acta Pharm; 2010 Mar; 60(1):55-71. PubMed ID: 20228041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues.
    Burguete A; Pontiki E; Hadjipavlou-Litina D; Villar R; Vicente E; Solano B; Ancizu S; Pérez-Silanes S; Aldana I; Monge A
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6439-43. PubMed ID: 17942306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.
    Kim DK; Jung SH; Lee HS; Dewang PM
    Eur J Med Chem; 2009 Feb; 44(2):568-76. PubMed ID: 18467006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
    Ghorab MM; Ragab FA; Hamed MM
    Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.